Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Biological Markers and Advanced Imaging for Prostate Cancer Progression in Active Surveillance [NA]
This clinical trial update describes research on biological markers and advanced imaging to monitor progression of low-risk prostate cancer …
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: TULIP ReTrain Study [NA]
This is a clinical trial update for the TULIP ReTrain study in prostate cancer. The study is currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer [Phase 2]
Phase 2 trial evaluating the combination of apalutamide and cetrelimab in treatment-emergent small cell neuroendocrine prostate cancer was t…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy [Phase 2]
A phase 2 neoadjuvant trial evaluating atezolizumab-based combination therapy in men with localized prostate cancer prior to radical prostat…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer [Phase 1]
Phase 1 clinical trial assessing cabazitaxel combined with radiation and hormone therapy for prostate cancer has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy [NA]
An update on a clinical trial investigating stereotactic body radiotherapy after prostatectomy for prostate cancer; the study is currently a…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Maximal Tumor Eradication for Oligometastatic Prostate Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial investigating maximal tumor eradication for oligometastatic prostate cancer is currently recruiting.
-
CLINICAL_TRIALS other · 2025-05-15Clinical Trial Update: Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)
The EMPOWeR trial evaluating management and wellness strategies for prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Safety and Early Efficacy of Radical Prostatectomy for Newly Diagnosed Very High Risk Locally Advanced and Oligometastatic Prostate Cancer [NA]
This clinical trial update reports on safety and early efficacy outcomes for performing radical prostatectomy in men newly diagnosed with ve…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients [EARLY_Phase 1]
A completed early-phase trial explored resistance training with or without creatine in patients with metastatic prostate cancer, focusing on…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: A Trial of Ipatasertib in Combination With Atezolizumab [Phase 1, Phase 2]
Update on a Phase 1/2 trial of ipatasertib in combination with atezolizumab for solid tumors, including glioblastoma multiforme and metastat…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Salvage Lymph Node Dissection in Prostate Cancer Patients With Recurrence After Radical Prostatectomy [NA]
A completed clinical trial evaluating salvage lymph node dissection for patients with recurrent prostate cancer after radical prostatectomy …
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Value of Ultra-fast Prostate MRI in Prostate Cancer
This clinical trial evaluated the value of ultra-fast MRI for imaging in prostate cancer and has completed.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Implementation of a Multimodal Prehabilitation Program in Robotic Oncological Surgery [NA]
This entry reports the completion of a clinical trial evaluating a multimodal prehabilitation program in robotic oncologic surgery. The stud…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer [Phase 1]
Phase 1 trial evaluating ARRx in combination with enzalutamide for metastatic castration-resistant prostate cancer was terminated, with resu…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: 177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study [Phase 2]
The LUNAR study is a Phase 2 trial evaluating 177Lu-PSMA therapy before stereotactic body radiotherapy in oligometastatic or recurrent prost…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Lutetium Lu-177 JH020002 Injection for advanced prostate cancer is currently recruiting, sponsored by Bivision…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
This clinical trial update describes a study that combines quantitative MRI and artificial intelligence to improve prostate cancer classific…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Multicenter Randomized Trial of 68Ga-PSMA-11 PET/CT Based SRT After Radical Prostatectomy [Phase 3]
Phase 3 multicenter randomized trial evaluating 68Ga-PSMA-11 PET/CT-guided salvage radiotherapy after radical prostatectomy for recurrent pr…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Hemi-Gland Cryoablation for Prostate Cancer at UCLA
This UCLA clinical trial update describes ongoing enrollment for hemi-gland cryoablation as a treatment for localized prostate cancer. Enrol…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Active Surveillance for Cancer of the Prostate (ASCaP)
Clinical trial update for the Active Surveillance for Cancer of the Prostate (ASCaP) study, which is currently recruiting for prostate cance…
-
FDA approval · 2025-05-13FDA Approved: DOCETAXEL — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approves a generic docetaxel product under an original ANDA for Meitheal Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First) [Phase 2]
Phase 2 study ZZ-First evaluating the combination of enzalutamide and talazoparib in metastatic hormone-sensitive prostate cancer has comple…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer [NA]
The trial evaluating spot-scanning based hypofractionated proton therapy for low- and intermediate-risk prostate cancer has been terminated.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: ExosomeDx in MRI-negative Men With High PSA [NA]
Clinical trial update on the ExosomeDx diagnostic for MRI-negative men with high PSA to evaluate suspected prostate cancer. The study status…